present
select
type
prosthet
heart
valv
surgic
correct
acquir
cardiac
failur
repres
topic
issu
modern
medicin
biolog
mechan
prosthet
heart
valv
avail
option
particular
xenogen
tissu
treat
fix
preserv
solut
appli
former
wherea
latter
variou
synthet
materi
appli
plastic
polym
etc
perhap
one
criteria
select
type
prosthesi
might
respons
immun
system
implant
xenogen
materi
inde
foreign
bodi
liter
place
blood
flow
constantli
contact
blood
cell
surround
tissu
could
eventu
caus
inflammatori
perhap
autoimmun
reaction
charact
intens
reaction
subject
thorough
investig
order
one
hand
select
proper
prosthet
heart
valv
hand
develop
approach
improv
prosthes
prevent
complic
dysfunct
previous
found
biolog
compar
mechan
prosthes
may
caus
inflammatori
complic
despit
data
longterm
studi
reveal
signific
differ
biolog
mechan
prosthes
term
subsequ
complic
previous
type
immun
respons
develop
implant
prosthesi
discuss
well
rang
cell
infiltr
prosthesi
examin
demonstr
cell
infiltr
pannu
investig
remov
biolog
mechan
prosthes
upon
quantiti
cell
found
insid
infiltr
differ
vari
depend
intens
local
inflammatori
respons
cellular
compon
present
lymphocyt
examin
remov
mechan
prosthes
demonstr
contain
factor
viii
cell
upon
verifi
infecti
etiolog
prosthet
failur
compar
infectionfre
sampl
case
lack
infect
accompani
mark
fibrosi
inflammatori
infiltr
mainli
contain
lymphocyt
macrophag
develop
similar
compar
examin
remov
biolog
prosthet
heart
valv
demonstr
profound
infiltr
prosthet
tissu
macrophag
cell
occur
case
prosthet
dysfunct
analyz
remov
medtron
freestyl
bioprosthes
averag
implant
durat
month
found
sign
chronic
inflammatori
reaction
affect
xenograft
arteri
wall
observ
case
infiltr
consist
macrophag
lymphocyt
includ
b
cell
studi
conclud
cell
respond
implant
foreign
porcin
tissu
develop
signific
damag
host
aortic
wall
assum
inadequ
fix
tissu
porcin
aorta
result
subsequ
retain
antigen
might
one
potenti
caus
develop
inflamm
hypothesi
confirm
regard
caus
underli
develop
immun
reaction
implant
biolog
tissu
relat
residu
antigen
anim
origin
retain
despit
special
treatment
decellular
becom
evid
mechan
biolog
prosthet
heart
valv
associ
tissu
reaction
develop
implant
foreign
materi
upon
macrophag
neutrophil
cell
major
player
cellular
immun
process
howev
dynam
chang
quantiti
system
blood
flow
particip
pathogenesi
respons
foreign
materi
potenti
diagnost
import
poorli
investig
connect
studi
aim
assess
cell
subset
peripher
blood
recipi
longterm
function
biolog
mechan
heart
valv
prosthes
sampl
peripher
blood
ulnar
vein
collect
patient
healthi
volunt
test
tube
contain
character
cell
phenotyp
follow
combin
monoclon
antibodi
beckman
coulter
usa
use
antihuman
cat
clone
antihuman
cat
clone
antihuman
cat
clone
antihuman
cat
clone
antihuman
cat
clone
antihuman
cat
clone
antihuman
cat
clone
antihuman
cat
clone
antihuman
cat
clone
briefli
peripher
blood
cell
stain
combin
antibodi
accord
manufactur
instruct
minut
dark
room
temperatur
follow
lyse
red
blood
cell
versalys
lyse
solut
cat
beckman
coulter
usa
absolut
number
leukocyt
lymphocyt
granulocyt
monocyt
count
use
hematolog
analyz
nihon
kohden
japan
stain
sampl
analyz
run
fourcolor
flow
cytometri
facscalibur
bectondickinson
usa
navio
beckman
coulter
usa
mathemat
process
flow
cytometri
data
perform
use
beckman
coulter
usa
softwar
threshold
set
forwardscatt
fsc
paramet
exclud
cell
debri
ssc
fsc
set
done
linear
amplif
logarithm
amplif
scale
use
fluoresc
channel
dot
plot
analysi
isotypematch
control
ab
fluorescenceminuson
gate
techniqu
use
evalu
threshold
posit
individu
antibodi
follow
cell
subset
analyz
n
central
memori
cm
effector
memori
em
termin
differenti
effector
memori
temra
accord
express
lymphocyt
cell
gate
accord
forwardscatt
fsc
sidescatt
ssc
properti
repres
bivari
dot
plot
isol
lymphocyt
popul
human
peripher
blood
sampl
present
helper
cytotox
cell
shown
dot
plot
respect
immunophenotyp
done
analyz
flow
cytometri
data
costain
cell
surfac
marker
fscssc
gate
lymphocyt
respect
figur
statist
analysi
data
done
use
statistica
graphpad
prism
softwar
data
present
median
valu
interquartil
rang
signific
differ
data
evalu
appli
nonparametr
mannwhitney
u
test
wwilcoxon
test
correl
analysi
done
use
spearman
rtest
signific
level
set
p
multivari
comparison
done
use
discrimin
analysi
stepwis
analysi
enumer
step
p
valu
signific
level
ftest
perform
discrimin
level
evalu
assess
wilk
lambda
signific
identifi
criterion
determin
draw
scatterplot
canon
valu
calcul
classif
valu
mahalanobi
squar
distanc
paramet
hemogram
wbc
total
count
neutrophil
lymphocyt
monocyt
shown
lack
differ
patient
biolog
mechan
heart
valv
prosthes
well
healthi
volunt
tabl
examin
cell
arm
immun
found
recipi
biolog
mechan
heart
valv
prosthes
differ
term
rel
absolut
count
examin
cell
subset
time
paramet
shown
differ
compar
healthi
volunt
tabl
recipi
mechan
biolog
heart
valv
prosthes
found
reduc
count
cell
compar
healthi
volunt
patient
biolog
prosthes
significantli
lower
rel
absolut
amount
cm
tcyt
tcyt
compar
healthi
volunt
convers
amount
temra
tcyt
temra
th
cell
elev
patient
mechan
heart
valv
prosthes
document
increas
rel
absolut
amount
temra
tcyt
compar
healthi
volunt
addit
rel
amount
th
cell
also
found
declin
compar
healthi
volunt
contrast
signific
differ
found
examin
paramet
cell
subset
patient
biolog
heart
valv
prosthes
versu
healthi
volunt
moreov
correl
hemogram
paramet
durat
prosthesi
function
reveal
well
repres
distribut
cell
subset
among
patient
mechan
versu
biolog
heart
valv
prosthes
shown
figur
discrimin
analysi
done
use
forward
stepwis
model
consist
step
demonstr
highest
signific
level
verifi
count
temra
tcyt
rel
rel
th
rel
em
tcyt
rel
rel
tcyt
ab
temra
th
rel
tabl
partit
examin
group
base
result
discrimin
analysi
depict
figur
group
biolog
prosthesi
recipi
possibl
analyz
effect
comorbid
chang
cell
subpopul
signific
chang
patient
without
chronic
ischem
heart
diseas
diseas
urinari
system
pulmonari
thyroid
diseas
signific
differ
biolog
prosthesi
recipi
comorbid
diabet
hyperton
diseas
acut
cerebrovascular
accid
gitract
diseas
present
tabl
among
surfac
marker
use
studi
variou
isoform
longest
histori
practic
applic
earli
demonstr
known
protein
may
consid
marker
unprim
cell
wherea
antibodi
recogn
bind
memori
cell
current
known
cell
express
molecul
contain
domain
within
sequenc
howev
start
antigenspecif
differenti
matur
cell
begin
express
isoform
result
mrna
splice
within
exon
follow
exon
b
c
gene
product
contain
domain
known
molecular
weight
kda
wherea
product
deriv
final
rna
modif
lack
domain
denot
kda
current
function
signific
variou
isoform
remain
poorli
investig
true
rest
surfac
marker
use
phenotyp
main
stage
matur
cell
picker
et
al
first
describ
lselectin
molecul
determin
direct
migrat
cell
traffick
peripher
lymphoid
tissu
moreov
also
demonstr
cell
mainli
express
wherea
matur
might
separ
cell
popul
latter
subset
bear
adhes
molecul
respons
cell
migrat
bodi
peripher
tissu
current
consid
marker
determin
migrat
cell
peripher
blood
stain
molecul
cell
surfac
allow
denot
central
memori
cell
within
pool
circulatori
lymphocyt
lack
surfac
marker
effector
memori
termin
differenti
effector
cell
temra
account
fact
cell
subset
function
within
nonlymphoid
tissu
central
memori
cell
character
surfac
express
instead
well
forth
main
differ
cell
subset
cell
alreadi
pass
antigenspecif
differenti
occur
within
secondari
lymphoid
tissu
presenc
surfac
cell
allow
distinguish
effector
memori
cell
phenotyp
featur
tcm
allow
circul
around
bodi
long
period
time
determin
preferenti
locat
insid
secondari
lymphoid
tissu
upon
antigen
stimul
antigen
present
cell
possess
cognat
surfac
ligand
allow
rapidli
activ
cell
high
express
level
follow
success
format
antigenspecif
cell
clone
moreov
central
memori
cell
better
secret
wherea
effector
memori
cell
effect
synthes
effector
cytokin
previous
role
cell
subset
reject
graft
organ
investig
particular
patient
morpholog
verifi
acut
reject
reaction
transplant
kidney
also
compar
healthi
volunt
found
possess
differenti
cell
termin
stage
chronic
renal
failur
addit
patient
acut
reject
reaction
note
sign
dysregul
cell
profil
bear
elev
amount
total
cell
includ
cell
lower
count
termin
differenti
memori
cell
howev
function
assay
demonstr
latter
subset
upregul
proinflammatori
cytotox
capac
anoth
studi
patient
normal
function
transplant
kidney
examin
among
increas
amount
termin
differenti
memori
cell
patient
associ
restrict
tcr
repertoir
patient
graft
dysfunct
median
age
year
document
increas
risk
develop
graft
dysfunct
observ
patient
elev
amount
temra
cell
found
patient
reactiv
stage
kidney
graft
reject
elev
rel
count
memori
tem
termin
differenti
temra
cell
compar
patient
quiescenc
stage
healthi
volunt
case
acut
reject
signific
decreas
count
temra
document
high
diagnost
signific
increas
level
temra
reciproc
decreas
cell
observ
patient
bone
marrow
transplant
develop
chronic
graft
versu
host
diseas
investig
cell
subset
repertoir
peripher
blood
patient
implant
biolog
mechan
heart
valv
prosthes
demonstr
cell
strongli
respond
foreign
materi
despit
fact
signific
differ
examin
paramet
cell
immun
found
recipi
differ
type
prosthes
howev
significantli
differ
compar
healthi
volunt
assum
alter
composit
cell
subset
name
decreas
count
cm
tcyt
tcyt
parallel
elev
amount
emra
tcyt
emra
th
point
develop
xenograft
reject
reaction
mechan
biolog
heart
valv
prosthes
importantli
pronounc
reject
reaction
biolog
prosthes
seem
despit
special
treatment
biolog
materi
graft
tissu
quit
larg
amount
xenogen
tissu
antigen
still
remain
swine
valv
apparatu
cell
monocyt
becom
stimul
foreign
antigen
also
provok
migrat
donor
tissu
situ
activ
result
releas
huge
amount
proinflammatori
cytokin
particular
whole
set
biolog
activ
molecul
may
display
proosteogen
activ
support
local
inflammatori
reaction
also
lead
collagen
degrad
deposit
hydroxyapatit
altogeth
local
inflammatori
degen
chang
within
prosthet
tissu
may
result
prosthesi
dysfunct
despit
fact
correl
chang
cell
subset
repertoir
sign
prosthesi
dysfunct
well
durat
prosthesi
function
found
howev
may
assum
immun
cell
involv
develop
local
chang
within
prosthet
tissu
time
result
discrimin
analysi
suggest
cell
subset
recipi
biolog
mechan
heart
valv
prosthes
display
distinguish
sign
respons
graft
tissu
moreov
futur
might
possibl
determin
diagnost
relev
paramet
cell
subset
properti
use
earli
diagnost
hostversusgraft
reaction
unfortun
articl
describ
peripher
cell
subset
chang
heart
diseas
well
comorbid
nevertheless
tri
find
impact
cell
subset
composit
studi
patient
acut
myocardi
infarct
undergo
primari
percutan
coronari
intervent
found
cytomegalovirusseroposit
patient
demonstr
greater
fall
concentr
termin
differenti
effector
memori
cell
peripher
blood
first
minut
reperfus
compar
cytomegalovirusseroneg
patient
moreov
signific
proport
temra
cell
remain
deplet
month
cytomegalovirusseroposit
patient
herebi
myocardi
ischemia
reperfus
cytomegalovirusseroposit
patient
lead
acut
loss
antigenspecif
termin
differenti
cell
type
diabet
autoimmun
process
pathogenes
pathway
compar
type
nevertheless
studi
patient
type
diabet
found
percentag
absolut
number
cm
n
cell
reduc
wherea
temra
cell
markedli
increas
indic
intermedi
longterm
glycaem
control
associ
neg
number
cm
n
cell
posit
number
temra
cell
author
conclud
consider
accumul
temra
cell
suggest
lifelong
stimul
protract
antigen
exposur
virus
agent
residu
selfantigen
homeostat
defect
regulationcontract
immun
respons
studi
tlymphocyt
subset
patient
sever
acut
respiratori
syndrom
sar
investig
found
cell
count
remark
decreas
week
infect
week
cell
count
subset
still
less
normal
control
compar
week
author
conclud
take
week
cell
subset
reach
normal
level
sar
research
found
signific
differ
patient
without
comorbid
diabet
hyperton
diseas
acut
cerebrovascular
accid
gitract
diseas
common
trend
hypothes
chronic
diseas
could
lead
chang
cell
popul
particip
immun
system
meanwhil
decreas
rel
absolut
number
central
memori
increas
number
patient
biolog
prosthesi
common
trend
regardless
presenc
comorbid
assum
chang
relat
develop
xenograft
reject
reaction
current
studi
contain
follow
limit
number
examin
patient
implant
mechan
prosthes
low
person
durat
prosthesi
function
significantli
shorter
group
compar
patient
biolog
heart
valv
prosthes
take
togeth
limit
may
lead
loss
signific
differ
patient
mechan
prosthesi
compar
recipi
biolog
prosthesi
healthi
volunt
